Importance of perioperative glycemic control in general surgery: a report from the Surgical Care and Outcomes Assessment Program
TLDR
Perioperative hyperglycemia was associated with adverse outcomes in general surgery patients with and without diabetes, and a dose-effect relationship was found between the effectiveness of insulin-related glucose control (worst 180–250mg/dL, best <130 mg/dL) and adverse outcomes.Abstract:
Objective: To determine the relationship of perioperative hyperglycemia and insulin administration on outcomes in elective colon/rectal and bariatric operations. Background: There is limited evidence to characterize the impact of perioperative hyperglycemia and insulin on adverse outcomes in patients, with and without diabetes, undergoing general surgical procedures. Methods: The Surgical Care and Outcomes Assessment Program is a Washington State quality improvement benchmarking-based initiative. We evaluated the relationship of perioperative hyperglycemia (>180 mg/dL) and insulin administration on mortality, reoperative interventions, and infections for patients undergoing elective colorectal and bariatric surgery at 47 participating hospitals between fourth quarter of 2005 and fourth quarter of 2010. Results: Of the 11,633 patients (55.4 ± 15.3 years; 65.7% women) with a serum glucose determination on the day of surgery, postoperative day 1, or postoperative day 2, 29.1% of patients were hyperglycemic. After controlling for clinical factors, those with hyperglycemia had a significantly increased risk of infection [odds ratio (OR) 2.0; 95% confidence interval (CI), 1.63–2.44], reoperative interventions (OR, 1.8; 95% CI, 1.41–2.3), and death (OR, 2.71; 95% CI, 1.72–4.28). Increased risk of poor outcomes was observed both for patients with and without diabetes. Those with hyperglycemia on the day of surgery who received insulin had no significant increase in infections (OR, 1.01; 95% CI, 0.72–1.42), reoperative interventions (OR, 1.29; 95% CI, 0.89– 1.89), or deaths (OR, 1.21; 95% CI, 0.61–2.42). A dose-effect relationship was found between the effectiveness of insulin-related glucose control (worst 180–250 mg/dL, best <130 mg/dL) and adverse outcomes. Conclusions: Perioperative hyperglycemia was associated with adverse outcomes in general surgery patients with and without diabetes. However, patients with hyperglycemia who received insulin were at no greater risk than those with normal blood glucoses. Perioperative glucose evaluation and insulin administration in patients with hyperglycemia are important quality targets.read more
Citations
More filters
Standards of Medical Care in Diabetes
TL;DR: These standards of care are intended to provide clinicians, patients, researchers, payors, and other interested individuals with the components of diabetes care, treatment goals, and tools to evaluate the quality of care.
Journal ArticleDOI
Strategies to Prevent Surgical Site Infections in Acute Care Hospitals: 2014 Update
Deverick J. Anderson,Kelly Podgorny,Sandra I. Berríos-Torres,Dale W. Bratzler,E. Patchen Dellinger,Linda Greene,Ann-Christine Nyquist,Lisa Saiman,Deborah S. Yokoe,Lisa L. Maragakis,Keith S. Kaye +10 more
TL;DR: This document updates “Strategies to Prevent Surgical Site Infections in Acute Care Hospitals,” published in 2008, with practical recommendations in a concise format designed to assist acute care hospitals in implementing and prioritizing their surgical site infection prevention efforts.
Journal ArticleDOI
ACOG practice bulletin: Clinical management guidelines for obstetrician-gynecologists
Journal ArticleDOI
American association of clinical endocrinologists and american college of endocrinology - clinical practice guidelines for developing a diabetes mellitus comprehensive care plan - 2015.
Yehuda Handelsman,Zachary T. Bloomgarden,George Grunberger,Guillermo E. Umpierrez,Robert S. Zimmerman,Timothy S. Bailey,Lawrence Blonde,George A. Bray,A. Jay Cohen,Samuel Dagogo-Jack,Jaime A. Davidson,Daniel Einhorn,Om P. Ganda,Alan J. Garber,W. Timothy Garvey,Robert R. Henry,Irl B. Hirsch,Edward S. Horton,Daniel L. Hurley,Paul S. Jellinger,Lois Jovanovič,Harold E. Lebovitz,Derek LeRoith,Philip T. Levy,Janet B. McGill,Jeffrey I. Mechanick,Jorge H. Mestman,Etie S. Moghissi,Eric A. Orzeck,Rachel Pessah-Pollack,Paul D. Rosenblit,Aaron I. Vinik,Kathleen Wyne,Farhad Zangeneh +33 more
TL;DR: These guidelines are a working document that reflects the state of the field at the time of publication and any decision by practitioners to apply these guidelines must be made in light of local resources and individual patient circumstances.
Journal ArticleDOI
American College of Surgeons and Surgical Infection Society: Surgical Site Infection Guidelines, 2016 Update
Kristen A. Ban,Kristen A. Ban,Joseph P. Minei,Christine Laronga,Brian G. Harbrecht,Eric H. Jensen,Donald E. Fry,Kamal M.F. Itani,E. Patchen Dellinger,Clifford Y. Ko,Clifford Y. Ko,Therese M. Duane +11 more
TL;DR: This data indicates that pre-emptive surgery is a viable option for the treatment of deep vein thrombosis in women with pre-operative indications and this work’s results support this view.
References
More filters
Journal ArticleDOI
Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases
TL;DR: It is concluded that the adapted comorbidity index will be useful in studies of disease outcome and resource use employing administrative databases.
Standards of Medical Care in Diabetes
TL;DR: These standards of care are intended to provide clinicians, patients, researchers, payors, and other interested individuals with the components of diabetes care, treatment goals, and tools to evaluate the quality of care.
Journal ArticleDOI
Intensive Insulin Therapy in Critically Ill Patients
Greet Van den Berghe,Pieter Wouters,Frank Weekers,Charles Verwaest,Frans Bruyninckx,Miet Schetz,Dirk Vlasselaers,Patrick Ferdinande,Peter Lauwers,Roger Bouillon +9 more
TL;DR: Intensive insulin therapy to maintain blood glucose at or below 110 mg per deciliter reduces morbidity and mortality among critically ill patients in the surgical intensive care unit.
Journal ArticleDOI
Intensive versus conventional glucose control in critically ill patients.
Nice-Sugar Study Investigators,Dean R. Chittock,Steve Su,D. Blair,Denise Foster,Rinaldo Bellomo,Deborah J. Cook,Vinay Dhingra,Peter Dodek,Paul C. Hébert,William R. Henderson,Stephane Heritier,Daren K. Heyland,Colin McArthur,Ellen McDonald,Imogen Mitchell,Robyn Norton,J. Potter,Bruce G. Robinson,Juan J. Ronco +19 more
TL;DR: In this large, international, randomized trial, it was found that intensive glucose control increased mortality among adults in the ICU: a blood glucose target of 180 mg or less per deciliter resulted in lower mortality than did a target of 81 to 108 mg perDeciliter.
Journal ArticleDOI
Standards of Medical Care in Diabetes—2010
TL;DR: These standards of care are intended to provide clinicians, patients, researchers, payors, and other interested individuals with the components of diabetes care, general treatment goals, and tools to evaluate the quality of care.
Related Papers (5)
Intensive versus conventional glucose control in critically ill patients.
Nice-Sugar Study Investigators,Dean R. Chittock,Steve Su,D. Blair,Denise Foster,Rinaldo Bellomo,Deborah J. Cook,Vinay Dhingra,Peter Dodek,Paul C. Hébert,William R. Henderson,Stephane Heritier,Daren K. Heyland,Colin McArthur,Ellen McDonald,Imogen Mitchell,Robyn Norton,J. Potter,Bruce G. Robinson,Juan J. Ronco +19 more